Acute Pancreatitis Market Scope And Analysis

Report Code : TIPRE00017674
Category : Life Sciences

Status : Published
No. of Pages : 196

Buy Now

Acute Pancreatitis Market Scope and Key Players Analysis by 2030

Buy Now

Acute Pancreatitis Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 5,649.77 Million
Market Size by 2030	US$ 8,827.37 Million
Global CAGR (2022 - 2030)	5.7%
Historical Data	2020-2021
Forecast period	2023-2030
Segments Covered	By Offerings Medications Diagnosis By Causes Gallstones Alcoholism Genetic Disorders Infections By End User Hospitals Diagnostic Laboratories Ambulatory Surgical Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Abbott Laboratories GE HealthCare Technologies Inc Samsung Healthcare Koninklijke Philips NV Baxter International Inc Dynavax Technologies Corp Actim Oy Medtronic Plc Boston Scientific Corp Fresenius Kabi AG

Acute Pancreatitis Market News and Recent Developments

The acute pancreatitis market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the acute pancreatitis market are listed below:

Arrivo BioVentures announced that the Food and Drug Administration (FDA) has granted its subsidiary, Panafina Inc., Fast Track designation for its investigational new drug, RABI-767, for the treatment of acute pancreatitis predicted to progress to severe disease. RABI-767 is an investigational small-molecule lipase inhibitor that is administered by endoscopic ultrasound-guided peripancreatic injection. RABI-767 is currently being evaluated in a phase 2a trial in patients predicted to develop severe acute pancreatitis. (Source: Arrivo BioVentures, Press Release, July 2024)
CalciMedica Inc. announced that its collaborator, St. Jude Children's Research Hospital (SJCRH), presented data from the initial cohort of the Phase 1/2 CRSPA study of Auxora (zegocractin injectable emulsion) in asparaginase-induced pancreatic toxicity (AIPT) at the 65th Annual American Society of Hematology (ASH) Meeting & Exposition on December 2023, in San Diego, CA. (Source: CalciMedica Inc., Press Release, December 2023)

Acute Pancreatitis Market Report Coverage and Deliverables

The “Acute Pancreatitis Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

Acute pancreatitis market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Acute pancreatitis market trends, as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST and SWOT analysis
Acute pancreatitis market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the acute pancreatitis market
Detailed company profiles